Fig. 5From: Neoadjuvant treatment of pancreatic adenocarcinoma: a systematic review and meta-analysis of 5520 patientsForest plots depicting pooled estimates for stable disease at the time of restaging during or after neoadjuvant therapy. Only studies utilizing NCCN or AHBPA/SSO/SSAT criteria were included in the forest plotBack to article page